Session » Genetics, Genomics and Proteomics - Poster II

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1212

A Combined Large Scale Meta-Analysis Identifies COG6 As a Novel Shared Risk Locus for Rheumatoid Arthritis and Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1199

A Genome-Wide Association Study of Methotrexate-Pneumonitis in Rheumatoid Arthritis: Results from the Pneumonitis Study Consortium

9:00AM-11:00AM: Abstract Number: 1210

A Genome-Wide Association Study of Psoriatic Arthritis in Italian Population

9:00AM-11:00AM: Abstract Number: 1206

A Replication Study and Meta-Analysis Demonstrate the Influence of the mtDNA Haplogroups in the Rate of Incident Knee Osteoarthritis. Functional Explanation of This Association Using Transmitochondrial Cybrids

9:00AM-11:00AM: Abstract Number: 1211

Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants

9:00AM-11:00AM: Abstract Number: 1214

Autoantibody Reactivities Correlated with SLE Disease Activity Identified By the SLE-key® iCHIP® Platform

9:00AM-11:00AM: Abstract Number: 1197

Certain Serum Micro-RNAs Are Associated with Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1202

Characteristic Compositional and Functional Alteration of Gut Microbiota in Patients with Behcet’s Disease

9:00AM-11:00AM: Abstract Number: 1201

Deconvolution of Immune Cell Proportions from Whole Blood RNA Using Next-Generation Sequencing

9:00AM-11:00AM: Abstract Number: 1207

Design of a Multiplex Serum Proteome Assay to Monitor Biologic Drug Response in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1219

Differential Peripheral Blood DNA Methylation Patterns Are Predictive of Radiographic OA Progression

9:00AM-11:00AM: Abstract Number: 1203

Differential Synovial Expression Patterns in Early Osteoarthritis Predict Pain and Progression of Joint Damage

9:00AM-11:00AM: Abstract Number: 1218

Extensive Genetic Overlap of Traits Related to Gout, Hyperuricemia and Its Comorbidities

9:00AM-11:00AM: Abstract Number: 1198

Gene Enrichment Analysis Identifies Active CD40-CD40L Signaling in Early and Established Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1208

High-Throughput Screening Discovers Multiple Novel Autoantibodies in Rheumatoid Arthritis, Systemic Lupus, Systemic Sclerosis and Sjogrens Syndrome

9:00AM-11:00AM: Abstract Number: 1217

Identification of Sjogren’s Syndrome-Associated Long Non-Coding RNAs That Are Co-Expressed with Key Protein-Coding Transcripts Involved in Dysregulated Interferon Responses

9:00AM-11:00AM: Abstract Number: 1205

In silico Drug Repurposing Analysis Supports Phosphoinositol 3 Kinase Inhibitors As Treatment of LUPUS

9:00AM-11:00AM: Abstract Number: 1215

Interferon Signature Genes Are Differentially Expressed Between Microscopic Polyangiitis and Systemic Lupus Erythematosus Peripheral Blood Transcriptomes

9:00AM-11:00AM: Abstract Number: 1204

Methotrexate Is an Antibacterial Drug Metabolized By Human Gut Bacteria

9:00AM-11:00AM: Abstract Number: 1216

Sjogren’s Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness

9:00AM-11:00AM: Abstract Number: 1209

Sporadic Hemophagocytic Lymphohistiocytosis (sHLH): A Polygenic Disease? a Report of French National, Prospective, Cohort of 205 Patients

9:00AM-11:00AM: Abstract Number: 1213

Targeted Next-Generation Sequencing of 128 Genes Associated with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1200

Transcriptional Profiling of Early RA Synovial Tissue Reveals the Impact of Triple DMARD Treatment on T Cell Activation Pathways

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].